Lixte Biotechnology Holdings's total assets for Q1 2026 were $10.87M, a decrease of -14.67% from the previous quarter. LIXT total liabilities were $1.69M for the fiscal quarter, a -4.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.